Patents by Inventor Mads Sabra

Mads Sabra has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9533069
    Abstract: Disclosed is a matrix material comprising a pharmaceutical composition such as a matrix material with a pharmaceutical composition printed on the surface. In one embodiment the pharmaceutical composition comprises thrombin. Further disclosed is a method for making the matrix material with a pharmaceutical composition printed on the surface and use of said matrix material for promotion of hemostasis and/or wound healing. Also disclosed is a kit-of-parts comprising a matrix with a pharmaceutical composition and a container with a peelable lid.
    Type: Grant
    Filed: December 20, 2013
    Date of Patent: January 3, 2017
    Assignee: Ferrosan Medical Devices A/S
    Inventors: Kristian Larsen, Mads Sabra
  • Publication number: 20140220130
    Abstract: The present invention relates to a matrix material comprising a pharmaceutical composition such as a matrix material with a pharmaceutical composition printed on the surface. In one embodiment the pharmaceutical composition comprises thrombin. The invention further describes a method for making the matrix material with a pharmaceutical composition printed on the surface. In one specific embodiment the invention also relates to the use of said matrix material for promotion of hemostasis and/or wound healing. The invention also relates to a kit-of-parts comprising a matrix with a pharmaceutical composition and a container with a peelable lid.
    Type: Application
    Filed: December 20, 2013
    Publication date: August 7, 2014
    Applicant: Ferrosan Medical Devices A/S
    Inventors: Kristian Larsen, Mads Sabra
  • Patent number: 8642831
    Abstract: A matrix material comprising a pharmaceutical composition printed on the surface is described. In one embodiment the pharmaceutical composition comprises thrombin. A method for making the matrix material with a pharmaceutical composition printed on the surface is also described. The matrix material can be used for promotion of hemostasis and/or wound healing. A kit-of-parts comprising a matrix with a pharmaceutical composition and a container with a peelable lid is described.
    Type: Grant
    Filed: February 27, 2009
    Date of Patent: February 4, 2014
    Assignee: Ferrosan Medical Devices A/S
    Inventors: Kristian Larsen, Mads Sabra
  • Publication number: 20110021964
    Abstract: The present invention relates to a matrix material comprising a pharmaceutical composition such as a matrix material with a pharmaceutical composition printed on the surface. In one embodiment the pharmaceutical composition comprises thrombin. The invention further describes a method for making the matrix material with a pharmaceutical composition printed on the surface. In one specific embodiment the invention also relates to the use of said matrix material for promotion of hemostasis and/or wound healing. The invention also relates to a kit-of-parts comprising a matrix with a pharmaceutical composition and a container with a peelable lid.
    Type: Application
    Filed: February 27, 2009
    Publication date: January 27, 2011
    Applicant: Ferrosan Medical Devices A/S
    Inventors: Kristian Larsen, Mads Sabra
  • Patent number: D839411
    Type: Grant
    Filed: June 14, 2017
    Date of Patent: January 29, 2019
    Assignee: Novartis AG
    Inventors: Tobias Wohlfahrt, Samuel Coendet, Johannes Egger, Gabriel Iobbi, Alain Schmidlin, Mads Sabra, Agathe Buffard, Muriel Didier, Erich Studer, Andrew Bryant
  • Patent number: D839412
    Type: Grant
    Filed: June 14, 2017
    Date of Patent: January 29, 2019
    Assignee: Novartis AG
    Inventors: Tobias Wohlfahrt, Samuel Coendet, Johannes Egger, Gabriel Iobbi, Alain Schmidlin, Mads Sabra, Agathe Buffard, Muriel Didier, Erich Studer, Andrew Bryant
  • Patent number: D839413
    Type: Grant
    Filed: June 14, 2017
    Date of Patent: January 29, 2019
    Assignee: Novartis AG
    Inventors: Tobias Wohlfahrt, Samuel Coendet, Johannes Egger, Gabriel Iobbi, Alain Schmidlin, Mads Sabra, Agathe Buffard, Muriel Didier, Erich Studer, Andrew Bryant
  • Patent number: D839414
    Type: Grant
    Filed: June 14, 2017
    Date of Patent: January 29, 2019
    Assignee: Novartis AG
    Inventors: Tobias Wohlfahrt, Samuel Coendet, Johannes Egger, Gabriel Iobbi, Alain Schmidlin, Mads Sabra, Agathe Buffard, Muriel Didier, Erich Studer, Andrew Bryant
  • Patent number: D839415
    Type: Grant
    Filed: June 14, 2017
    Date of Patent: January 29, 2019
    Assignee: Novartis AG
    Inventors: Tobias Wohlfahrt, Samuel Coendet, Johannes Egger, Gabriel Iobbi, Alain Schmidlin, Mads Sabra, Agathe Buffard, Muriel Didier, Erich Studer, Andrew Bryant
  • Patent number: D839416
    Type: Grant
    Filed: June 14, 2017
    Date of Patent: January 29, 2019
    Assignee: Novartis AG
    Inventors: Tobias Wohlfahrt, Samuel Coendet, Johannes Egger, Gabriel Iobbi, Alain Schmidlin, Mads Sabra, Agathe Buffard, Muriel Didier, Erich Studer, Andrew Bryant